Ota Y - Search Results

1

Neurovirulence test for oral live poliovaccines using poliovirus-sensitive transgenic mice.

Abe S, Ota Y, Koike S, Kurata T, Horie H, Nomura T, Hashizume S, Nomoto A. Abe S, et al. Among authors: ota y. Virology. 1995 Feb 1;206(2):1075-83. doi: 10.1006/viro.1995.1030. Virology. 1995. PMID: 7856082 Free article.

2

Studies on neurovirulence in poliovirus-sensitive transgenic mice and cynomolgus monkeys for the different temperature-sensitive viruses derived from the Sabin type 3 virus.

Abe S, Ota Y, Doi Y, Nomoto A, Nomura T, Chumakov KM, Hashizume S. Abe S, et al. Among authors: ota y. Virology. 1995 Jun 20;210(1):160-6. doi: 10.1006/viro.1995.1327. Virology. 1995. PMID: 7793068 Free article.

3

Transgenic mice carrying the human poliovirus receptor: new animal models for study of poliovirus neurovirulence.

Horie H, Koike S, Kurata T, Sato-Yoshida Y, Ise I, Ota Y, Abe S, Hioki K, Kato H, Taya C, et al. Horie H, et al. Among authors: ota y. J Virol. 1994 Feb;68(2):681-8. doi: 10.1128/JVI.68.2.681-688.1994. J Virol. 1994. PMID: 8289371 Free PMC article.

4

Host range phenotype induced by mutations in the internal ribosomal entry site of poliovirus RNA.

Shiroki K, Ishii T, Aoki T, Ota Y, Yang WX, Komatsu T, Ami Y, Arita M, Abe S, Hashizume S, Nomoto A. Shiroki K, et al. Among authors: ota y. J Virol. 1997 Jan;71(1):1-8. doi: 10.1128/JVI.71.1.1-8.1997. J Virol. 1997. PMID: 8985316 Free PMC article.

5

Neurovirulence of type 1 polioviruses isolated from sewage in Japan.

Horie H, Yoshida H, Matsuura K, Miyazawa M, Ota Y, Nakayama T, Doi Y, Hashizume S. Horie H, et al. Among authors: ota y. Appl Environ Microbiol. 2002 Jan;68(1):138-42. doi: 10.1128/AEM.68.1.138-142.2002. Appl Environ Microbiol. 2002. PMID: 11772619 Free PMC article.

6

Detection of mutants in polio vaccine viruses using pooled antipoliovirus monoclonal antibodies.

Horie H, Sato-Miyazawa M, Ota Y, Wakabayashi K, Doi T, Yoshizawa K, Doi Y, Hashizume S. Horie H, et al. Among authors: ota y. Biologicals. 1999 Sep;27(3):217-26. doi: 10.1006/biol.1999.0211. Biologicals. 1999. PMID: 10652177

7

Analysis of the accumulation of mutants in Sabin attenuated polio vaccine viruses passaged in Vero cells.

Horie H, Miyazawa M, Ota Y, Wakabayashi K, Yoshida H, Doi Y, Hashizume S. Horie H, et al. Among authors: ota y. Vaccine. 2001 Jan 8;19(11-12):1456-9. doi: 10.1016/s0264-410x(00)00350-9. Vaccine. 2001. PMID: 11163668

8

Progress with inactivated poliovirus vaccines derived from the Sabin strains.

Doi Y, Abe S, Yamamoto H, Horie H, Ohyama H, Satoh K, Tano Y, Ota Y, Miyazawa M, Wakabayashi K, Hashizume S. Doi Y, et al. Among authors: ota y. Dev Biol (Basel). 2001;105:163-9. Dev Biol (Basel). 2001. PMID: 11763324 Clinical Trial.

9

Development of inactivated poliovirus vaccine derived from Sabin strains.

Simizu B, Abe S, Yamamoto H, Tano Y, Ota Y, Miyazawa M, Horie H, Satoh K, Wakabayashi K. Simizu B, et al. Among authors: ota y. Biologicals. 2006 Jun;34(2):151-4. doi: 10.1016/j.biologicals.2006.02.010. Epub 2006 May 5. Biologicals. 2006. PMID: 16679028

10

A national reference for inactivated polio vaccine derived from Sabin strains in Japan.

Shirato H, Someya Y, Ochiai M, Horiuchi Y, Takahashi M, Takeda N, Wakabayashi K, Ouchi Y, Ota Y, Tano Y, Abe S, Yamazaki S, Wakita T; sIPV Evaluation Group of NIID-Virology II. Shirato H, et al. Among authors: ota y. Vaccine. 2014 Sep 8;32(40):5163-9. doi: 10.1016/j.vaccine.2014.07.065. Epub 2014 Jul 30. Vaccine. 2014. PMID: 25090648

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,447 results

Search Page

Filters